Literature DB >> 9406145

Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall.

L Saward1, P Zahradka.   

Abstract

A method for establishing primary cultures of smooth muscle cells (SMCs) from the porcine coronary artery without either microdissection and/or enzymatic dispersion was developed using selective migration of cells from coronary explants in vitro. This culture method relies on the heterogeneity of cell types and differences in their migration and adherence ability to separate SMC from contaminating fibroblasts or endothelial cells. The cell type was determined by immunohistochemical staining with monoclonal antibodies to SM alpha-actin, SM myosin, h-caldesmon and von Willebrand factor. The first wave of migration (1-7 days) consisted of a mixture of fibroblasts and SMCs. Only SMCs were present in the second wave of migration (7-14 days). Endothelial cells, which exhibited a lower capacity for migration and adherence, were restricted to the third wave of migration (14-21 days). Cells obtained from the second wave of migration exhibited the characteristic single-layered, aligned, hill-and-valley pattern of SMCs when confluent. Quiescence was attained 4-5 days after removal of serum, as established by [3H]-thymidine incorporation. Stimulation of the quiescent SMCs with 20% FBS resulted in a synchronous re-entry into the cell-cycle with S phase reached 15-18 h later. The SMCs prepared using this protocol thus exhibit the structural markers and capacity to undergo phenotypic modulation that are characteristic of SMCs in vivo. This approach to establishing primary cultures of SMCs offers the advantage of selecting for the subpopulation of cells capable of migration in response to injury or growth factor stimulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406145

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  13 in total

Review 1.  The smooth muscle cell in culture.

Authors:  J Chamley-Campbell; G R Campbell; R Ross
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

2.  SMOOTH MUSCLE CELLS IN AORTIC CULTURES OF UNTREATED AND CHOLESTEROL-FED RABBITS.

Authors:  T KASAI; O J POLLAK
Journal:  Z Zellforsch Mikrosk Anat       Date:  1964-05-29

3.  Human vascular smooth muscle in culture. Growth and ultrastructure.

Authors:  M A Gimbrone; R S Cotran
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

4.  Different electrical responses to vasoactive agonists in morphologically distinct smooth muscle cell types.

Authors:  C B Neylon; P V Avdonin; R J Dilley; M A Larsen; V A Tkachuk; A Bobik
Journal:  Circ Res       Date:  1994-10       Impact factor: 17.367

Review 5.  The intima. Soil for atherosclerosis and restenosis.

Authors:  S M Schwartz; D deBlois; E R O'Brien
Journal:  Circ Res       Date:  1995-09       Impact factor: 17.367

6.  Immunodetection of activated mitogen-activated protein kinase in vascular tissues.

Authors:  L Yau; P Zahradka
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 7.  A reassessment of endothelial injury and arterial lesion formation.

Authors:  M A Reidy
Journal:  Lab Invest       Date:  1985-11       Impact factor: 5.662

8.  Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells.

Authors:  C M Shanahan; P L Weissberg; J C Metcalfe
Journal:  Circ Res       Date:  1993-07       Impact factor: 17.367

9.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers.

Authors:  R Ross
Journal:  J Cell Biol       Date:  1971-07       Impact factor: 10.539

10.  Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization.

Authors:  D D Wagner; V J Marder
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

View more
  14 in total

1.  Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Abdul Manaf Ali; Abdul Rahman Omar; Maryam Mohit; Ehsan Janzamin; Fazel Sahraneshin Samani; Zahra Torshizi; Seyed Noureddin Nematollahi-Mahani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-01-25       Impact factor: 2.416

2.  Chronic hypoxia and VEGF differentially modulate abundance and organization of myosin heavy chain isoforms in fetal and adult ovine arteries.

Authors:  Margaret C Hubbell; Andrew J Semotiuk; Richard B Thorpe; Olayemi O Adeoye; Stacy M Butler; James M Williams; Omid Khorram; William J Pearce
Journal:  Am J Physiol Cell Physiol       Date:  2012-09-19       Impact factor: 4.249

3.  The cyclic AMP response element-binding protein (CREB) mediates smooth muscle cell proliferation in response to angiotensin II.

Authors:  Peter Molnar; Raissa Perrault; Sherif Louis; Peter Zahradka
Journal:  J Cell Commun Signal       Date:  2013-12-11       Impact factor: 5.782

4.  Chlamydophila pneumoniae infection leads to smooth muscle cell proliferation and thickening in the coronary artery without contributions from a host immune response.

Authors:  Justin F Deniset; Paul K M Cheung; Elena Dibrov; Kaitlin Lee; Sarah Steigerwald; Grant N Pierce
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

5.  Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome.

Authors:  X Cui; M Chopp; A Zacharek; J Dai; C Zhang; T Yan; R Ning; C Roberts; A Shehadah; N Kuzmin-Nichols; C D Sanberg; J Chen
Journal:  Neuroscience       Date:  2012-10-04       Impact factor: 3.590

6.  Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing.

Authors:  Darren H Freed; Michael C Moon; Anna M Borowiec; Stephen C Jones; Peter Zahradka; Ian M C Dixon
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

7.  Niaspan treatment increases tumor necrosis factor-alpha-converting enzyme and promotes arteriogenesis after stroke.

Authors:  Jieli Chen; Xu Cui; Alex Zacharek; Guang Liang Ding; Amjad Shehadah; Quan Jiang; Mei Lu; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2009-02-18       Impact factor: 6.200

8.  Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke.

Authors:  Alex Zacharek; Jieli Chen; Xu Cui; Yuping Yang; Michael Chopp
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

9.  Role of endothelial nitric oxide synthetase in arteriogenesis after stroke in mice.

Authors:  X Cui; M Chopp; A Zacharek; C Zhang; C Roberts; J Chen
Journal:  Neuroscience       Date:  2009-01-06       Impact factor: 3.590

10.  Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels.

Authors:  David Wilson; Hamid Massaeli; Grant N Pierce; Peter Zahradka
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.